7-151559046-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016203.4(PRKAG2):​c.1678+1478G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 985,176 control chromosomes in the GnomAD database, including 199,910 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 23720 hom., cov: 33)
Exomes 𝑓: 0.65 ( 176190 hom. )

Consequence

PRKAG2
NM_016203.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.11

Publications

9 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.695 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKAG2NM_016203.4 linkc.1678+1478G>A intron_variant Intron 15 of 15 ENST00000287878.9 NP_057287.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKAG2ENST00000287878.9 linkc.1678+1478G>A intron_variant Intron 15 of 15 1 NM_016203.4 ENSP00000287878.3

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80296
AN:
151978
Hom.:
23709
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.241
Gnomad AMI
AF:
0.420
Gnomad AMR
AF:
0.548
Gnomad ASJ
AF:
0.657
Gnomad EAS
AF:
0.714
Gnomad SAS
AF:
0.631
Gnomad FIN
AF:
0.691
Gnomad MID
AF:
0.557
Gnomad NFE
AF:
0.646
Gnomad OTH
AF:
0.554
GnomAD4 exome
AF:
0.647
AC:
539062
AN:
833080
Hom.:
176190
Cov.:
43
AF XY:
0.647
AC XY:
248820
AN XY:
384706
show subpopulations
African (AFR)
AF:
0.193
AC:
3053
AN:
15786
American (AMR)
AF:
0.553
AC:
544
AN:
984
Ashkenazi Jewish (ASJ)
AF:
0.656
AC:
3381
AN:
5152
East Asian (EAS)
AF:
0.715
AC:
2596
AN:
3630
South Asian (SAS)
AF:
0.642
AC:
10558
AN:
16458
European-Finnish (FIN)
AF:
0.699
AC:
193
AN:
276
Middle Eastern (MID)
AF:
0.593
AC:
959
AN:
1618
European-Non Finnish (NFE)
AF:
0.657
AC:
500455
AN:
761882
Other (OTH)
AF:
0.635
AC:
17323
AN:
27294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
11619
23237
34856
46474
58093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17788
35576
53364
71152
88940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.528
AC:
80324
AN:
152096
Hom.:
23720
Cov.:
33
AF XY:
0.535
AC XY:
39743
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.240
AC:
9971
AN:
41472
American (AMR)
AF:
0.548
AC:
8386
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.657
AC:
2279
AN:
3470
East Asian (EAS)
AF:
0.715
AC:
3681
AN:
5150
South Asian (SAS)
AF:
0.632
AC:
3048
AN:
4824
European-Finnish (FIN)
AF:
0.691
AC:
7312
AN:
10576
Middle Eastern (MID)
AF:
0.568
AC:
167
AN:
294
European-Non Finnish (NFE)
AF:
0.646
AC:
43916
AN:
67996
Other (OTH)
AF:
0.559
AC:
1182
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1730
3460
5191
6921
8651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.611
Hom.:
15564
Bravo
AF:
0.504
Asia WGS
AF:
0.626
AC:
2178
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.6
DANN
Benign
0.84
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4726050; hg19: chr7-151256132; API